Expertise StarJohns Hopkins and CareFirst BlueCross BlueShield, the businesses investing in early-stage startups, have introduced the launch of a brand new healthcare accelerator program designed to assist early-stage entrepreneurs utilizing synthetic intelligence to enhance entry to care.
With assist from Johns Hopkins College and CareFirst, Techstars AI Well being Baltimore leverages the college’s experience to rework analysis findings into commercially viable companies.
It additionally leverages CareFirst’s expertise in selling entry to inexpensive, equitable, high-quality well being care and Techstars’ accelerator mannequin.
The Baltimore-based accelerator program goals to construct on the success of Techstars Equitech, a three-part sequence in partnership with UpSurge Baltimore that concluded in Might.
UpSurge, Baltimore’s expertise ecosystem builder, will proceed to make sure that Techstars founders can leverage the broad continuum of current belongings within the larger Baltimore area.
Adam Phillips, former managing director of Techstars Equitech, will spearhead the 13-week program targeted on supporting entrepreneurs main healthtech, medtech and biotech start-ups.
Startups will obtain funding, professional steerage and different assist wanted to navigate the advanced healthcare ecosystem and regulatory surroundings.
Purposes open August twenty sixth and shall be accepted till November twentieth.
Myra Norton, Director of Startup Acceleration Johns Hopkins Expertise Ventures, the college’s commercialization and entrepreneurship arm, stated, “By partnering with Techstars on the intersection of healthcare and synthetic intelligence, Johns Hopkins goals to carry extra entrepreneurs to our ecosystem and promote extra entrepreneurial exercise to carry high-impact healthcare innovation to the world.
bigger development
exist In 2021, Techstars was one of many traders in UAEs Klaim, a well being expertise startup that raised $1.6 million (€1.4 million) in pre-Collection A funding. The funding permits Klaim to enter the Saudi Arabian and US markets.
August 15, Johns Hopkins Kimmel Most cancers Middle researchers reveal a brand new take a look at might give gastroenterologists perception into which sufferers with Barrett’s esophagus are more likely to progress to esophageal most cancers or irregular cells referred to as high-grade dysplasia collect. This info will help docs decide the best way to monitor or handle sufferers throughout scientific care.
In July, Johns Hopkins Expertise Ventures introduced Particular nanoparticles are developed that may ship gene remedy instantly to varied varieties of cells within the bone marrow to right disease-causing mutations.
That very same month, researchers used genetic engineering strategies to The Johns Hopkins Kimmel Most cancers Middle and its Ludwig Middle, the Lustgarten Laboratory and the Bloomberg~Kimmel Institute for Most cancers Immunotherapy have engineered a brand new sort of cell to acknowledge and battle most cancers.
Different corporations providing healthcare accelerator packages embrace Duke-NUS Medical Faculty launched LIVE Ventures, a US$20 million incubator in July to assist commercialize tutorial analysis packages and translate scientific breakthroughs into scientific functions.
The incubator goals to supply tutorial innovators with experience and assets from the private and non-private sectors – together with pharmaceutical corporations, market information analysis professionals, traders and trade specialists – Conduct product market suitability evaluation for venture commercialization.
Mayo Clinic’s Platform_Accelerate is a 30-week program designed to assist early-stage well being expertise AI startups turn out to be market-ready.
Penn HealthTech’s HealthTech Accelerator is a year-long cohort program designed to speed up the lifecycle of modern well being applied sciences with assist by means of recommendation and funding.
The HIMSS Synthetic Intelligence Healthcare Discussion board is scheduled to be held in Boston on September 5-6. Be taught extra and register.